Insights

Strong Funding & Support MaaT Pharma has secured substantial financial backing with over 44 million dollars in funding, including recent loans from the European Investment Bank, indicating robust financial health and potential for expansion of their microbiome-driven therapies.

Innovative Leadership The company has been recognized as an innovative enterprise by Bpifrance and is leading the development of microbiome-based immunomodulators in oncology, positioning it as a key player in cutting-edge cancer therapy markets.

Strategic Collaborations Recent partnerships with global pharmaceutical services providers like Clinigen demonstrate MaaT Pharma's focus on commercializing its therapies across Europe, opening opportunities for sales in clinical and regulatory support services.

Advancing Clinical Trials With positive results from Phase 3 trials for MaaT013 and ongoing presentations at major hematology and oncology events, MaaT Pharma is nearing market entry, creating a promising pipeline for sales of microbiome therapeutics.

Growing Market Presence Listed on Euronext Paris and actively participating in international conferences, MaaT Pharma is establishing a strong market presence, offering opportunities for sales collaborations in biotech, life sciences, and healthcare sectors seeking innovative solutions.

Similar companies to MaaT Pharma

MaaT Pharma Tech Stack

MaaT Pharma uses 8 technology products and services including Gravatar, RStudio, Select2, and more. Explore MaaT Pharma's tech stack below.

  • Gravatar
    Audio, Video, Graphics
  • RStudio
    Integrated Development Environments
  • Select2
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Google Maps
    Maps
  • PHP
    Programming Languages
  • Animate.css
    UI Frameworks
  • MailChimp for WordPress
    Web Platform Extensions

Media & News

MaaT Pharma's Email Address Formats

MaaT Pharma uses at least 1 format(s):
MaaT Pharma Email FormatsExamplePercentage
First.Last@maatpharma.comJohn.Doe@maatpharma.com
33%
FLast@maatpharma.comJDoe@maatpharma.com
17%
LF@maatpharma.comDJ@maatpharma.com
17%
First.Last@maatpharma.comJohn.Doe@maatpharma.com
33%

Frequently Asked Questions

Where is MaaT Pharma's headquarters located?

Minus sign iconPlus sign icon
MaaT Pharma's main headquarters is located at 70 Avenue Tony Garnier, Lyon, 69007, FR. The company has employees across 3 continents, including EuropeNorth AmericaAfrica.

What is MaaT Pharma's phone number?

Minus sign iconPlus sign icon
You can contact MaaT Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MaaT Pharma's official website and social media links?

Minus sign iconPlus sign icon
MaaT Pharma's official website is maatpharma.com and has social profiles on LinkedInCrunchbase.

What is MaaT Pharma's SIC code NAICS code?

Minus sign iconPlus sign icon
MaaT Pharma's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MaaT Pharma have currently?

Minus sign iconPlus sign icon
As of October 2025, MaaT Pharma has approximately 79 employees across 3 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Business Officer: J. C.Chief Medical Officer: G. P.Chief Technology Officer: C. S.. Explore MaaT Pharma's employee directory with LeadIQ.

What industry does MaaT Pharma belong to?

Minus sign iconPlus sign icon
MaaT Pharma operates in the Biotechnology Research industry.

What technology does MaaT Pharma use?

Minus sign iconPlus sign icon
MaaT Pharma's tech stack includes GravatarRStudioSelect2jQueryGoogle MapsPHPAnimate.cssMailChimp for WordPress.

What is MaaT Pharma's email format?

Minus sign iconPlus sign icon
MaaT Pharma's email format typically follows the pattern of First.Last@maatpharma.com. Find more MaaT Pharma email formats with LeadIQ.

How much funding has MaaT Pharma raised to date?

Minus sign iconPlus sign icon
As of October 2025, MaaT Pharma has raised $44M in funding. The last funding round occurred on Jul 28, 2025 for $44M.

When was MaaT Pharma founded?

Minus sign iconPlus sign icon
MaaT Pharma was founded in 2014.

MaaT Pharma

Biotechnology ResearchFrance51-200 Employees

MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France. As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed on Euronext Paris (ticker: MAAT) since 2021.

Section iconCompany Overview

Headquarters
70 Avenue Tony Garnier, Lyon, 69007, FR
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $44M

    MaaT Pharma has raised a total of $44M of funding over 9 rounds. Their latest funding round was raised on Jul 28, 2025 in the amount of $44M.

  • $1M

    MaaT Pharma's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $44M

    MaaT Pharma has raised a total of $44M of funding over 9 rounds. Their latest funding round was raised on Jul 28, 2025 in the amount of $44M.

  • $1M

    MaaT Pharma's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.